𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Relationship between CAG repeat length and brain volume in premanifest and early Huntington’s disease

✍ Scribed by S. M. D. Henley; E. J. Wild; N. Z. Hobbs; R. I. Scahill; G. R. Ridgway; D. G. MacManus; R. A. Barker; N. C. Fox; S. J. Tabrizi

Publisher
Springer
Year
2009
Tongue
English
Weight
388 KB
Volume
256
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The relationship between CAG repeat leng
The relationship between CAG repeat length and clinical progression in Huntington's disease
✍ Bernard Ravina; Megan Romer; Radu Constantinescu; Kevin Biglan; Alicia Brocht; K 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 1 views

## Abstract The objective of this study was to examine the relationship between CAG repeat length (CAGn) and clinical progression in patients with Huntington's disease (HD). There are conflicting reports about the relationship between CAGn and clinical progression of HD. We conducted an analysis of

Age, CAG repeat length, and clinical pro
Age, CAG repeat length, and clinical progression in Huntington's disease
✍ Adam Rosenblatt; Brahma V. Kumar; Alisa Mo; Claire S. Welsh; Russell L. Margolis 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 834 KB

## Abstract The objective of this study was to further explore the effect of CAG repeat length on the rate of clinical progression in patients with Huntington's disease. The dataset included records for 569 subjects followed prospectively at the Baltimore Huntington's Disease Center. Participants w

Rate and acceleration of whole-brain atr
Rate and acceleration of whole-brain atrophy in premanifest and early Huntington's disease
✍ Edward J. Wild; Susie M.D. Henley; Nicola Z. Hobbs; Chris Frost; David G. MacMan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB 👁 1 views

Huntington's disease (HD) produces progressive and ultimately widespread impairment of brain function. Neostriatal atrophy alone cannot account for whole-brain losses seen postmortem, and the mutant huntingtin protein and its neuropathologic sequelae are evident throughout the brain. Whole-brain atr

Whole-brain atrophy as a measure of prog
Whole-brain atrophy as a measure of progression in premanifest and early Huntington's disease
✍ Susie M.D. Henley; Edward J. Wild; Nicola Z. Hobbs; Chris Frost; David G. MacMan 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB 👁 1 views

## Abstract Therapeutic trials in Huntington's disease (HD) are challenging as clinical progression is slow and variable and reliable biomarkers are lacking. We used magnetic resonance imaging and the brain boundary shift integral to quantify whole‐brain atrophy rates over 1 year in early and prema